| Code | CSB-RA878853MB2HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to NG-004, targeting RTN4 (Reticulon-4), also known as Nogo-A. RTN4 is a membrane protein predominantly expressed in the central nervous system, where it functions as a potent inhibitor of neurite outgrowth and axonal regeneration. As a component of CNS myelin, RTN4 plays a critical role in limiting neuronal plasticity and restricting axonal regrowth following injury. This protein has been extensively studied in the context of spinal cord injury, stroke, and neurodegenerative diseases including multiple sclerosis and amyotrophic lateral sclerosis, where its inhibitory effects on neural repair represent a significant therapeutic challenge.
The reference antibody NG-004 has been utilized in neuroscience research to investigate RTN4-mediated inhibition of axonal regeneration and to explore potential therapeutic strategies for promoting neural recovery. This biosimilar antibody provides researchers with a reliable tool for studying RTN4 expression patterns, protein-protein interactions, and functional mechanisms in various neurological disease models. It supports investigations into neural regeneration, myelin-associated inhibition, and potential neuroprotective interventions.
There are currently no reviews for this product.